WHO monographs on selected medicinal plants - travolekar.ru

<strong>WHO</strong> <strong>monographs</strong> on selected medicinal plants
15. Kempe C et al. Isländisch-Moos-Pastillen zur Prophylaxe bzw. Heilung von
und ausgetrockneter Rachenschleimhaut [Icelandic moss lozenges in the prevention
or treatment of oral mucosa irritation and dried out throat mucosa].
Laryngorhinootologie, 1997, 76:186–188 [in German].
16. Vorberg G. Erfahrungsbericht: Flechtenwirkstoffe lindern Reizzustände der
Atemwege: Noben den entzündungshemmenden Eigenschaften wirkt sich
der Schleimhautschutz besonders günstig aus. Ärztliche Praxis, 1981,
85:3068.
17. Blumenthal M et al. The complete German Commission E <strong>monographs</strong>: therapeutic
guide to herbal medicines. Austin, TX, American Botanical Council,
1998.
18. Blumenthal M et al, eds. Herbal medicine: expanded Commission E <strong>monographs</strong>.
Newton, MA, Integrative Medicine Communications, 2000.
19. Lesiovskaya EE et al, eds. Pharmacotherapy with the principles of phytotherapy,
Moscow, Geotar-Med Publishers, 2003 [in Russian].
20. Mommsen H. [Icelandic moss as a drug.] Zeitschrift für Allgemeinmedizin,
1970, 46:1566–1567 [in German].
21. Ingolfsdottir K, Jurcic K, Wagner H. Immunomodulating polysaccharides
from aqueous extracts of Cetraria islandica (Iceland moss). Phytomedicine,
1998, 5:333–339.
22. Pengsuparp T et al. Mechanistic evaluation of new plant-derived compounds
that inhibit HIV-1 reverse transcriptase. Journal of Natural Products, 1995,
58:1024–1031.
23. Gulcin I et al. Determination of antioxidant activity of lichen Cetraria islandica
(L) Ach. Journal of Ethnopharmacology, 2002, 79:325–329.
24. Ogmundsdottir HM et al. Anti-proliferative effects of lichen-derived inhibitors
of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.
Journal of Pharmacy and Pharmacology, 1998, 50:107–115.
25. Ingolfsdottir K et al. Immunologically active polysaccharide from Cetraria
islandica. Planta Medica, 1994, 60:527–531.
26. Ingolfsdottir K et al. Antimycobacterial activity of lichen metabolites in vitro.
European Journal of Pharmaceutical Sciences, 1998, 6:141–144.
27. Olafsdottir ES et al. Immunologically active (1 3)-(1 4)-alpha-D-glucan
from Cetraria islandica. Phytomedicine, 1999, 6:33–39.
28. Airaksinen MM, Peura P, Antere S. Toxicity of Iceland lichen and reindeer
lichen. Archives of Toxicology (Suppl) 1986, 9:406–409.
29. Airaksinen MM et al. Toxicity of plant material used as emergency food during
famines in Finland. Journal of Ethnopharmacology, 1986, 18:273–296.
30. Hecker M, Volp A. Tolerability of Icelandic moss lozenges in upper respiratory
tract diseases – multicentric drug monitoring study with 3,143 children.
Forschende Komplementarmedizin und klassische Naturheilkunde, 2004,
11:76–82.
148